- REPORT SUMMARY
- TABLE OF CONTENTS
-
Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis is one of the most commonly observed eye problems across all age groups, generally caused by bacteria such as Staphylococcus aureus, Moraxella lacunata, Haemophilus influenza, and others (e.g. Chlamydia trachomatis, Proteus mirabilis, etc.).
The development of multi-drug resistant variants, which is resulting in the augmented use of drugs, is expected to boost market growth during the forecast period. Microbes such as Streptococcus or Staphylococcus are responsible for bacterial conjunctivitis. These microbes change themselves chemically to develop resistance to the drugs. Since this resistance develops due to the irrational use of antibiotics, it may lead to severe complications in the body of the patients. Patients are thus expected to take up more medications such as corticosteroids and higher doses of antibiotics for the treatment of such diseases. This augmented use of drugs like corticosteroids and antibiotics for the treatment of bacterial conjunctivitis will propel the prospects for growth in this market.The growing genericization of antibacterial drugs has impacted the demand for branded drugs significantly. The generic versions of patented formulations, with almost same efficiency as the latter, are easily available at much lower rates in the market. This has increased the sales volume, albeit at the cost of revenues. Many branded ophthalmic drug manufacturers have incurred huge losses due to the generic cannibalization in this market.The rising prevalence of multi-drug resistant organisms (MDROs), triggered by wide usage of antibiotics, incorrect drug dosage, and inappropriate medications, has created serious challenges for the treatment of infections such as bacterial conjunctivitis. Researchers across the world are working on discovering efficient drugs for these MDROs. However, the non-availability of effective medications in near future is likely to hamper the market’s growth over the coming years.
The report details the trend, potential and market size of Bacterial Conjunctivitis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bacterial Conjunctivitis Drugsmarket, defines the market attractiveness level of Bacterial Conjunctivitis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bacterial Conjunctivitis Drugs industry, describes the types of Bacterial Conjunctivitis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bacterial Conjunctivitis Drugs market and the development prospects and opportunities of Bacterial Conjunctivitis Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bacterial Conjunctivitis Drugs market in Chapter 13.
By Player:
Akorn
Bayer
Merck
Perrigo
Santen Pharmaceutical
By Type:
Fluoroquinolones
Aminoglycosides
Macrolides
Others
By End-User:
Infective (Viral and Bacterial)
Allergic
Irritant (Chemical)
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bacterial Conjunctivitis Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bacterial Conjunctivitis Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bacterial Conjunctivitis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bacterial Conjunctivitis Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bacterial Conjunctivitis Drugs Market Analysis and Outlook to 2022
-
7.1 Global Bacterial Conjunctivitis Drugs Consumption (2017-2022)
-
7.2 United States Bacterial Conjunctivitis Drugs Consumption (2017-2022)
-
7.3 Europe Bacterial Conjunctivitis Drugs Consumption (2017-2022)
-
7.4 China Bacterial Conjunctivitis Drugs Consumption (2017-2022)
-
7.5 Japan Bacterial Conjunctivitis Drugs Consumption (2017-2022)
-
7.6 India Bacterial Conjunctivitis Drugs Consumption (2017-2022)
-
7.7 South Korea Bacterial Conjunctivitis Drugs Consumption (2017-2022)
8 Region and Country-wise Bacterial Conjunctivitis Drugs Market Analysis and Outlook to 2028
-
8.1 Global Bacterial Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.2 United States Bacterial Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Bacterial Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.4 China Bacterial Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Bacterial Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.6 India Bacterial Conjunctivitis Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Bacterial Conjunctivitis Drugs Consumption Forecast (2022-2028)
9 Global Bacterial Conjunctivitis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Bacterial Conjunctivitis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Fluoroquinolones Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Aminoglycosides Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Macrolides Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Bacterial Conjunctivitis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Infective (Viral and Bacterial) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Allergic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Irritant (Chemical) Consumption and Growth Rate (2017-2022)
10 Global Bacterial Conjunctivitis Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Bacterial Conjunctivitis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Fluoroquinolones Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Aminoglycosides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Macrolides Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bacterial Conjunctivitis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Infective (Viral and Bacterial) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Allergic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Irritant (Chemical) Consumption Forecast and Growth Rate (2022-2028)
11 Global Bacterial Conjunctivitis Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bacterial Conjunctivitis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bacterial Conjunctivitis Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bacterial Conjunctivitis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bacterial Conjunctivitis Drugs Market Competitive Analysis
-
14.1 Akorn
-
14.1.1 Akorn Company Details
-
14.1.2 Akorn Bacterial Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Akorn Bacterial Conjunctivitis Drugs Product and Service
-
14.2 Bayer
-
14.2.1 Bayer Company Details
-
14.2.2 Bayer Bacterial Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer Bacterial Conjunctivitis Drugs Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Bacterial Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Bacterial Conjunctivitis Drugs Product and Service
-
14.4 Perrigo
-
14.4.1 Perrigo Company Details
-
14.4.2 Perrigo Bacterial Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Perrigo Bacterial Conjunctivitis Drugs Product and Service
-
14.5 Santen Pharmaceutical
-
14.5.1 Santen Pharmaceutical Company Details
-
14.5.2 Santen Pharmaceutical Bacterial Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Santen Pharmaceutical Bacterial Conjunctivitis Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bacterial Conjunctivitis Drugs
-
Figure Bacterial Conjunctivitis Drugs Picture
-
Table Global Bacterial Conjunctivitis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bacterial Conjunctivitis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bacterial Conjunctivitis Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bacterial Conjunctivitis Drugs Consumption by Country (2017-2022)
-
Figure United States Bacterial Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Bacterial Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Bacterial Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Bacterial Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Bacterial Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bacterial Conjunctivitis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Bacterial Conjunctivitis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Bacterial Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bacterial Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bacterial Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bacterial Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bacterial Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bacterial Conjunctivitis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fluoroquinolones Consumption and Growth Rate (2017-2022)
-
Figure Global Aminoglycosides Consumption and Growth Rate (2017-2022)
-
Figure Global Macrolides Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Infective (Viral and Bacterial) Consumption and Growth Rate (2017-2022)
-
Figure Global Allergic Consumption and Growth Rate (2017-2022)
-
Figure Global Irritant (Chemical) Consumption and Growth Rate (2017-2022)
-
Figure Global Fluoroquinolones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Aminoglycosides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Macrolides Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infective (Viral and Bacterial) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Allergic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Irritant (Chemical) Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bacterial Conjunctivitis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bacterial Conjunctivitis Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Akorn (Foundation Year, Company Profile and etc.)
-
Table Akorn Bacterial Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akorn Bacterial Conjunctivitis Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Bacterial Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Bacterial Conjunctivitis Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Bacterial Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Bacterial Conjunctivitis Drugs Product and Service
-
Table Perrigo (Foundation Year, Company Profile and etc.)
-
Table Perrigo Bacterial Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Perrigo Bacterial Conjunctivitis Drugs Product and Service
-
Table Santen Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Santen Pharmaceutical Bacterial Conjunctivitis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Santen Pharmaceutical Bacterial Conjunctivitis Drugs Product and Service
-